Cargando…
A Rapid Response to Matrix Therapy With RGTA in Severe Epidermolysis Bullosa
Autores principales: | Malaq, Ali Al, Barritault, Denis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Open Science Company, LLC
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3479950/ https://www.ncbi.nlm.nih.gov/pubmed/23150747 |
Ejemplares similares
-
Case Reports for Topical Treatment of Corneal Ulcers with a New Matrix Therapy Agent or RGTA(®) in Dogs
por: Martinez, Jessica A., et al.
Publicado: (2019) -
Vulvar involvement in epidermolysis bullosa: Case series
por: Dang, Julie, et al.
Publicado: (2021) -
ReGeneraTing Agents (RGTA
(®)) are a new option to improve amputation outcomes in the recovery of severe hand injuries
por: Ahmad, Roohi Sharifah, et al.
Publicado: (2018) -
ReGeneraTing Agents (rgta(®)) technology combined with antibiotics improves outcomes for infections in the upper limb
por: Roohi, Sharifah Ahmad, et al.
Publicado: (2021) -
Randomized controlled trial demonstrates the benefit of RGTA(®) based matrix therapy to treat tendinopathies in racing horses
por: Jacquet-Guibon, Sandrine, et al.
Publicado: (2018)